tiprankstipranks
Innovent Biologics (HK:1801)
:1801
Hong Kong Market
1801
Innovent Biologics
RESEARCH TOOLSreports
Want to see HK:1801 full AI Analyst Report?

Innovent Biologics (1801) Ratios

26 Followers

Innovent Biologics Ratios

HK:1801's free cash flow for Q4 2025 was ¥0.87. For the 2025 fiscal year, HK:1801's free cash flow was decreased by ¥ and operating cash flow was ¥0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.62 2.62 2.35 3.00 3.29
Quick Ratio
 2.47 2.47 2.16 2.78 2.88
Cash Ratio
 2.07 2.07 1.72 2.25 0.29
Solvency Ratio
 0.06 0.05 0.02 -0.08 -0.27
Operating Cash Flow Ratio
 1.15 1.19 0.29 0.03 -0.55
Short-Term Operating Cash Flow Coverage
 12.07 12.49 3.18 0.12 -2.16
Net Current Asset Value
¥ 4.82B¥ 4.82B¥ 1.79B¥ 5.33B¥ 4.65B
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.08 0.13 0.18 0.18
Debt-to-Equity Ratio
 0.15 0.15 0.22 0.29 0.30
Debt-to-Capital Ratio
 0.13 0.13 0.18 0.22 0.23
Long-Term Debt-to-Capital Ratio
 0.09 0.09 0.16 0.16 0.17
Financial Leverage Ratio
 1.93 1.93 1.65 1.65 1.64
Debt Service Coverage Ratio
 1.93 2.21 -1.05 -0.42 -1.78
Interest Coverage Ratio
 80.85 25.40 -11.17 -17.03 -30.71
Debt to Market Cap
 0.02 0.02 0.05 0.06 0.07
Interest Debt Per Share
 3.12 1.73 1.78 2.38 2.23
Net Debt to EBITDA
 -9.04 -7.38 9.74 9.73 -1.26
Profitability Margins
Gross Profit Margin
82.26%86.54%83.97%70.89%79.57%
EBIT Margin
11.28%15.50%-8.02%-16.85%-45.40%
EBITDA Margin
12.44%15.50%-5.10%-10.65%-38.39%
Operating Profit Margin
11.28%15.50%-8.02%-27.06%-68.54%
Pretax Profit Margin
6.50%6.43%-0.83%-18.44%-47.64%
Net Profit Margin
6.30%6.24%-1.00%-16.56%-47.83%
Continuous Operations Profit Margin
6.30%6.24%-1.00%-16.56%-47.83%
Net Income Per EBT
96.91%96.98%120.36%89.82%100.41%
EBT Per EBIT
57.62%41.50%10.40%68.15%69.50%
Return on Assets (ROA)
2.18%2.12%-0.44%-4.98%-12.39%
Return on Equity (ROE)
4.82%4.09%-0.72%-8.21%-20.31%
Return on Capital Employed (ROCE)
5.03%6.80%-4.39%-10.40%-22.16%
Return on Invested Capital (ROIC)
4.74%6.41%-4.28%-8.68%-20.81%
Return on Tangible Assets
2.27%2.21%-0.47%-4.99%-13.30%
Earnings Yield
1.14%0.69%-0.17%-1.70%-4.94%
Efficiency Ratios
Receivables Turnover
 7.38 7.25 6.01 6.17 5.00
Payables Turnover
 4.63 3.46 4.22 4.85 2.86
Inventory Turnover
 1.76 1.31 1.84 1.87 0.65
Fixed Asset Turnover
 2.37 2.33 1.67 1.33 1.12
Asset Turnover
 0.35 0.34 0.44 0.30 0.26
Working Capital Turnover Ratio
 1.19 1.30 1.27 0.73 0.55
Cash Conversion Cycle
 178.06 222.64 172.96 179.46 505.58
Days of Sales Outstanding
 49.48 50.33 60.70 59.16 73.04
Days of Inventory Outstanding
 207.37 277.88 198.71 195.56 560.20
Days of Payables Outstanding
 78.79 105.58 86.45 75.26 127.66
Operating Cycle
 256.85 328.22 259.41 254.72 633.24
Cash Flow Ratios
Operating Cash Flow Per Share
 10.63 5.96 0.79 0.09 -1.29
Free Cash Flow Per Share
 10.38 5.55 -0.26 -0.79 -2.21
CapEx Per Share
 0.25 0.41 1.05 0.89 0.93
Free Cash Flow to Operating Cash Flow
 0.98 0.93 -0.33 -8.36 1.72
Dividend Paid and CapEx Coverage Ratio
 42.34 14.64 0.75 0.11 -1.39
Capital Expenditure Coverage Ratio
 42.34 14.64 0.75 0.11 -1.39
Operating Cash Flow Coverage Ratio
 3.43 3.55 0.45 0.04 -0.59
Operating Cash Flow to Sales Ratio
 0.75 0.79 0.14 0.02 -0.42
Free Cash Flow Yield
6.91%8.11%-0.75%-2.05%-7.49%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 87.93 144.97 -591.18 -58.77 -20.23
Price-to-Sales (P/S) Ratio
 10.57 9.04 5.94 9.73 9.67
Price-to-Book (P/B) Ratio
 3.70 5.93 4.26 4.82 4.11
Price-to-Free Cash Flow (P/FCF) Ratio
 14.48 12.33 -133.71 -48.89 -13.35
Price-to-Operating Cash Flow Ratio
 7.41 11.49 43.47 408.73 -22.97
Price-to-Earnings Growth (PEG) Ratio
 0.10 -0.16 6.48 1.07 0.91
Price-to-Fair Value
 3.70 5.93 4.26 4.82 4.11
Enterprise Value Multiple
 75.91 50.96 -106.74 -81.71 -26.46
Enterprise Value
 122.07B 100.35B 51.27B 53.98B 46.29B
EV to EBITDA
 75.92 50.96 -106.74 -81.71 -26.46
EV to Sales
 9.45 7.90 5.44 8.70 10.16
EV to Free Cash Flow
 12.94 10.77 -122.53 -43.69 -14.03
EV to Operating Cash Flow
 12.64 10.03 39.83 365.21 -24.12
Tangible Book Value Per Share
 20.49 11.10 7.27 8.01 6.40
Shareholders’ Equity Per Share
 21.31 11.54 8.06 8.03 7.20
Tax and Other Ratios
Effective Tax Rate
 0.03 0.03 -0.20 0.10 >-0.01
Revenue Per Share
 14.22 7.57 5.79 3.98 3.06
Net Income Per Share
 0.90 0.47 -0.06 -0.66 -1.46
Tax Burden
 0.97 0.97 1.20 0.90 1.00
Interest Burden
 0.58 0.42 0.10 1.09 1.05
Research & Development to Revenue
 0.20 0.20 0.28 0.36 0.63
SG&A to Revenue
 0.51 0.51 0.54 0.12 0.18
Stock-Based Compensation to Revenue
 0.03 0.05 0.06 0.09 0.10
Income Quality
 11.87 11.92 -16.37 -0.13 0.88
Currency in CNY